What is Alvotech SA (ALVO)?
Alvotech SA is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. The company focuses on producing biologic therapies that are highly similar to existing branded biologics, aiming to increase accessibility and affordability of these treatments. Its portfolio includes biosimilars across various therapeutic areas such as oncology, immunology, and endocrinology. Alvotech operates research and development facilities as well as manufacturing sites designed to meet regulatory standards for biologics production. The company collaborates with partners and regulatory bodies to advance its product pipeline through clinical development and approval processes. Its activities contribute to the growing biosimilars market, which plays a role in healthcare cost management and patient access to biologic therapies.
Alvotech SA Stock Price Today: Live Overview
The price today is shaped by market activity, with iShares Aaa - A Rated Corporate Bond ETF trading at $3.13. Today’s price range ranges between $3.01 and $3.16, with a daily change of -1.2903%.
FAQ: Alvotech SA (ALVO)
What is the current price of ALVO stock?
The last traded price is $3.13.
Does ALVO pay dividends?
Alvotech SA pays dividends via cash distributions (if applicable).
Does ALVO have a formal corporate presence or regional headquarters in the UAE?
Alvotech SA has a registered presence in Dubai Internet City, UAE.
What is ALVO best known for?
The company is most famous for developing biosimilar medicines.
What assets are typically shown together with ALVO?
Commonly shown alongside ALVO: VanEck IG Floating Rate ETF, Vicat, Estee Lauder
Latest shares articles



